Roger Jeffs, PhD

Roger Jeffs is Co-Founder and Vice Chairman at Kriya. Roger was the President and co-CEO of United Ther­a­peu­tics Corporation, joining the company during its start-up phase in 1998. He helped lead the company’s IPO, oversaw the clinical development and regulatory approval of six products for rare diseases, and managed the commercial efforts that led to a $1.5B annual revenue run rate. He currently serves on the boards of Axsome Ther­a­peu­tics, Albireo Pharma and Liquidia Corporation. He previously served on the boards of United Ther­a­peu­tics, Sangamo Ther­a­peu­tics, and Dova Phar­ma­ceu­ti­cals. Roger received his PhD in phar­ma­col­o­gy from the University of North Carolina School of Medicine and his under­grad­u­ate degree in chemistry from Duke University.